You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CD122-Biased Agonist

Showing 1 - 25 of 1,836
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Melanoma Trial in Duarte, Portland, Philadelphia (Bempegaldesleukin (NKTR-214), Nivolumab, 8?Zr-Df-IAB22M2C)

Withdrawn
  • Metastatic Melanoma
  • Bempegaldesleukin (NKTR-214)
  • +2 more
  • Duarte, California
  • +2 more
Jun 28, 2021

Ependymoma, Ewing Sarcoma, High-grade Glioma Trial in Worldwide (Nivolumab, NKTR-214)

Completed
  • Ependymoma
  • +9 more
  • Nivolumab
  • NKTR-214
  • Little Rock, Arkansas
  • +17 more
Dec 8, 2022

Covid-19, Coronavirus Disease 2019 Trial in Hialeah, Winter Park, Mesquite (Bempegaldesleukin, Standard of Care, Placebo)

Completed
  • Covid-19
  • Coronavirus Disease 2019
  • Hialeah, Florida
  • +3 more
Mar 31, 2022

Melanoma, Merkel Cell Carcinoma, Triple Negative Breast Cancer Trial in United States (NKTR-262, bempegaldesleukin, nivolumab)

Terminated
  • Melanoma
  • +6 more
  • Scottsdale, Arizona
  • +13 more
Jun 24, 2022

Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma Trial in Worldwide (bempegaldesleukin, sunitinib, nivolumab)

Active, not recruiting
  • Renal Cell Carcinoma
  • Metastatic Renal Cell Carcinoma
  • bempegaldesleukin
  • +3 more
  • Anchorage, Alaska
  • +108 more
Mar 31, 2022

Acromegaly Trial in Worldwide (Paltusotine, Placebo)

Recruiting
  • Acromegaly
  • Phoenix, Arizona
  • +67 more
Aug 8, 2022

Acromegaly Trial in Worldwide (Paltusotine)

Completed
  • Acromegaly
  • Los Angeles, California
  • +44 more
Jul 27, 2021

Acute Respiratory Failure Trial in Ann Arbor (Artificial Intelligence model predictions without explanation, Artificial

Completed
  • Acute Respiratory Failure
  • Artificial Intelligence model predictions without explanation
  • +4 more
  • Ann Arbor, Michigan
    University of Michigan
Oct 17, 2023

Acute Pain, Burns, Adverse Drug Event Trial (Oliceridine, Historical opioid use)

Not yet recruiting
  • Acute Pain
  • +4 more
  • (no location specified)
Jul 25, 2022

Drug Effect Trial in Seoul (Remimazolam besylate)

Not yet recruiting
  • Drug Effect
  • Remimazolam besylate
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Aug 3, 2023

Overactive Bladder Syndrome Trial run by the (Vaginal estrogen, Mirabegron 50 MG [Myrbetriq])

Recruiting
  • Overactive Bladder Syndrome
  • Vaginal estrogen
  • Mirabegron 50 MG [Myrbetriq]
  • Bethesda, Maryland
    Walter Reed National Military Medical Center
Nov 3, 2022

Acromegaly Trial in Worldwide (Paltusotine, Placebo)

Completed
  • Acromegaly
  • Los Angeles, California
  • +44 more
Jul 13, 2021

Ankle Using High-density and Bipolar Surface EMG in Chronic

Completed
  • Stroke
  • +2 more
  • Electromyographic measurements
  • (no location specified)
Oct 19, 2023

Ovarian Stimulation, Human Chorionic Gonadotropin, Oocyte Donors Trial in Thessaloniki (Dual trigger (human chorionic

Recruiting
  • Ovarian Stimulation
  • +2 more
  • Dual trigger (human chorionic gonadotropin plus GnRH-agonist)
  • GnRH-agonist only trigger
  • Thessaloniki, Greece
    Embryolab Fertility Clinic
Nov 20, 2023

Insights Into Participating in Studies for Uterine Cancer

Not yet recruiting
  • Uterine Cancer
    • San Francisco, California
      Power Life Sciences
    Aug 11, 2023

    Testicular Cancer Clinical Trials

    Not yet recruiting
    • Testicular Cancer
      • San Francisco, California
        Power Life Sciences
      Jun 23, 2023

      Hair Diseases, Alopecia, Hair Loss Trial in Manaus (DA-OTC-002)

      Completed
      • Hair Diseases
      • +2 more
      • DA-OTC-002
      • Manaus, Brazil
        Hospital Oscar Nicolau
      Oct 20, 2023

      Remimazolam Trial (Remimazolam, remifantanil)

      Not yet recruiting
      • Remimazolam
      • (no location specified)
      Jun 26, 2022

      Semaglutide Use in Acute Pulmonary Embolism

      Completed
      • Pulmonary Embolism
      • London, United Kingdom
        Colm McCabe
      Nov 3, 2023

      Type 2 Diabetes, Diabetes, Type 2 Trial (Tirzepatide)

      Not yet recruiting
      • Type 2 Diabetes
      • Diabetes Mellitus, Type 2
      • (no location specified)
      Feb 6, 2023

      Arterial Stiffness, Hypertension, Cardiovascular Diseases Trial in Prague (Cardiovascular fitness)

      Active, not recruiting
      • Arterial Stiffness
      • +2 more
      • Cardiovascular fitness
      • Prague, Czechia
      • +1 more
      Sep 14, 2023

      Patient Perspectives in Squamous Cell Carcinoma Clinical Trials

      Not yet recruiting
      • Squamous Cell Carcinoma
        • San Francisco, California
          Power Life Sciences
        Jun 23, 2023

        Advanced Solid Tumor, Locally Advanced Solid Tumor, Metastatic Solid Tumor Trial in Australia, United States (TransCon TLR7/8

        Recruiting
        • Advanced Solid Tumor
        • +6 more
        • Duarte, California
        • +12 more
        Sep 21, 2022

        The Experiences of Patients In Schizophrenia Research

        Not yet recruiting
        • Schizophrenia
          • (no location specified)
          May 12, 2023

          Exercise Performance Trial in Copenhagen (Indacaterol and Mometasonefluroate (low dose), Placebo, Indacaterol and

          Recruiting
          • Exercise Performance
          • Indacaterol and Mometasonefluroate (low dose)
          • +2 more
          • Copenhagen, Denmark
            August Krogh Building
          Oct 4, 2023